A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment



Status:Completed
Conditions:Depression, Depression, Major Depression Disorder (MDD)
Therapuetic Areas:Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 70
Updated:12/23/2017
Start Date:November 2013
End Date:October 2014

Use our guide to learn which trials are right for you!

The current study will evaluate the antidepressant effect of CERC-301 during 28 days of
treatment in subjects with MDD who are currently experiencing a severe depressive episode
despite stable ongoing treatment with selective serotonin- or serotonin-norepinephrine
reuptake inhibitors (SSRI or SNRI). The study population will be enriched for subjects that
would benefit most from rapid onset, those with recent active suicidal ideation, but not a
risk to themselves or others and are deemed appropriate for an out-patient study with careful
safety surveillance. This will allow the study to focus on the antidepressant effects of
CERC-301 but also explore effects on suicidal ideation. To explore rapid onset, the primary
endpoint will be at 7 days, but effects over the 28 days of treatment will be examined as a
secondary endpoint.


Inclusion Criteria:

1. Male or female 18 to 70 years of age inclusive.

2. Females must be either:

1. Post-menopausal (amenorrhea for at least 12 consecutive months), surgically
sterile -or-

2. Women of childbearing potential (WOCBP) meeting the criteria below:

i. Uses an acceptable double-barrier method of contraception as determined by the
Investigator -and- ii. Is not lactating, has a negative serum beta human chorionic
gonadotropin pregnancy test at screening and a negative urine pregnancy test prior to
randomization on Day 0.

3. Male subjects must agree to use a condom if partner is of childbearing potential.

4. Diagnosis of MDD recurrent without psychotic features according to Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
criteria with diagnosis confirmed using the Structured Clinical Interview for DSM-IV
Axis I Disorders Clinical Trials Version (SCID-CT).

5. Currently adhering to antidepressant drug regimen that consists of stable SSRI or SNRI
therapy

6. Inadequate antidepressant response to current antidepressant therapy despite adequate
dose and duration

7. HDRS-17 score ≥ 21 on the HDRS-17 performed by the site at screening

8. Recent active suicidal ideation defined as a score of 2 on the intensity of ideation
section on the Columbia-Suicide Severity Rating Scale (C-SSRS) during the four weeks
prior to screening using the "Baseline/Screening" version of the C-SSRS.

9. In otherwise good general health without any unstable medical conditions (as
determined by medical history, physical examination, 12-lead ECG, clinical laboratory
testing, etc.).

Exclusion Criteria:

1. History of substance abuse or dependence within the 3 months prior to screening.

2. Positive urine drug test at screening and prior to randomization on Day 0 unless due
to a permitted medication that is documented in the subject's medication history.

3. Positive ethanol breath test at screening and/or prior to randomization on Day 0.

4. Elevated semi-recumbent blood pressure at screening and prior to randomization on Day
0, defined as systolic blood pressure > 140 mm Hg and diastolic blood pressure

5. Active, comorbid disease that might limit the ability of the subject to participate in
the study as determined by the Investigator (i.e. poorly controlled diabetes mellitus,
unstable angina, coronary artery disease, congestive heart failure, etc.).

6. Subjects with clinical laboratory test abnormality deemed clinically significant by
the Investigator at screening.

7. Axis I diagnosis of obsessive compulsive disorder, posttraumatic stress disorder,
bipolar I or II mood disorders, eating disorders (e.g., anorexia nervosa, bulimia
nervosa), psychotic disorders (e.g., schizoaffective disorder, schizophrenia),
significant cognitive disorders (e.g., delirium, dementia, amnesia), or dissociative
disorders.

8. Subjects with Axis II diagnosis of borderline, antisocial, paranoid, schizoid,
schizotypal, or histrionic personality disorder.

9. Subjects with a neurologic disorder that could cause or contribute to depression
(e.g., Alzheimer's disease, Parkinson's disease).

10. Female subjects currently experiencing postpartum depression.

11. Subjects who, in the opinion of the Investigator, are not appropriate for a 35-day
placebo-controlled study due to risk of significant threat to self or others during
screening or study conduct.

12. Use of other NMDA-receptor modulators (e.g., dextromethorphan, ketamine, amantadine,
memantine) within 30 days of screening and throughout the study.

13. The following concomitant medication use is excluded within six weeks prior to
screening:

- Bupropion or tricyclic antidepressants

- Intermittent, symptomatic use of benzodiazepines (e.g. symptomatic treatment of
anxiety or panic attacks)

- Antipsychotics

- Lithium

- Any medications known to directly interact with central or peripheral
serotonergic receptors, other than the permitted antidepressants.

- Any medications known to directly interact with central noradrenergic receptors,
other than the permitted antidepressants.

14. Electroconvulsive therapy, transcranial magnetic stimulation, or vagal nerve
stimulation during the current depressive episode.

15. Participation in an investigational drug or device study within the 6 months prior to
screening.

16. Subjects with suicidal behavior within 6 months prior to screening as measured by the
C-SSRS "Baseline/Screening" version.

17. Subjects with a C-SSRS score > 2 on the intensity of ideation section at randomization
(Visit 2a), using the "Since Last Visit" version of the C-SSRS.
We found this trial at
24
sites
Garden Grove, California 92845
?
mi
from
Garden Grove, CA
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
811 Juniper St NE
Atlanta, Georgia 30308
(404) 881-5800
Atlanta Center for Medical Research Welcome to the Atlanta Center for Medical Research, a leader...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Baltimore, Maryland 21285
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bellevue, Washington 98007
?
mi
from
Bellevue, WA
Click here to add this to my saved trials
?
mi
from
Canton, OH
Click here to add this to my saved trials
25 East Washington Street
Chicago, Illinois 60602
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Culver City, California 90230
?
mi
from
Culver City, CA
Click here to add this to my saved trials
Dallas, Texas 75231
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Glendale, California 91204
?
mi
from
Glendale, CA
Click here to add this to my saved trials
Jacksonville, Florida 32216
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Marietta, Georgia 30060
?
mi
from
Marietta, GA
Click here to add this to my saved trials
Media, Pennsylvania 19063
?
mi
from
Media, PA
Click here to add this to my saved trials
Mount Kisco, New York 10549
?
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
National City, California 91950
?
mi
from
National City, CA
Click here to add this to my saved trials
New York, New York 10128
?
mi
from
New York, NY
Click here to add this to my saved trials
North Miami, Florida 33161
?
mi
from
North Miami, FL
Click here to add this to my saved trials
4132 Keaton Crossing Boulevard
O'Fallon, Missouri 63368
?
mi
from
O'Fallon, MO
Click here to add this to my saved trials
901 Clay Street
Oakland, California 94612
?
mi
from
Oakland, CA
Click here to add this to my saved trials
3998 Vista Way
Oceanside, California 92056
?
mi
from
Oceanside, CA
Click here to add this to my saved trials
Orlando, Florida 32806
?
mi
from
Orlando, FL
Click here to add this to my saved trials
16601 North 40th Street
Phoenix, Arizona 85032
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Rochester, New York 14618
?
mi
from
Rochester, NY
Click here to add this to my saved trials
San Diego, California 92123
?
mi
from
San Diego, CA
Click here to add this to my saved trials